Atara Starts Two Phase 3 Trials of Treatment for Lymphoma That Arises from a Transplant
News
Atara Biotherapeutics is conducting two Phase 3 clinical trials of a treatment for a transplant-related disorder that can include lymphoma. The company developed tabelecleucel (ATA129) for people whose dormant Epstein-Barr virus can ... Read more